Schedule 13G ownership disclosure

APRICUS BIOSCIENCES INC

Security class unavailable · CUSIP: 03832V307

Event date: 2018-03-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-18-004177
Form type
SC 13G
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Apr 09, 2018
Reporting period
Mar 28, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub